Gag Clause or Non-Disclosure Agreement
AB 315: Mandating PBM Registration and Disclosures – An Important Step to Increasing Drug Price Transparency and Competition
Sammy Chang, Health Policy Researcher September 25, 2018
AB 315, considered to be a complementary bill to SB 17, which mandated prescription drug pricing transparency, is an important bill that would ensure more transparency of pharmacy benefit managers (PBMs) by regulating PBMs and gathering data on how PBMs impact the dispensing of certain prescription drugs. The intent of the bill is to allow consumers to purchase drugs at the lowest price by allowing purchasers, like health plans, to keep PBMs accountable for the savings PBMs promised. However, this bill almost didn’t come to be. AB 315 was sent …
Continue Reading Download PDF
Source Short: Senate Passes Legislation Banning Gag-clauses in Pharmacy Contracts
Katie Gudiksen, Senior Health Policy Researcher September 19, 2018
On Monday, September 17, the Senate overwhelmingly passed S.2554, the Patient Right to Know Drug Prices Act, with a vote of 98-2.[1] Congress appears to be building on the momentum of recent state action to prohibit gag-clauses that prevent pharmacists from telling insured patients when the cost of their co-payment exceeds the cash price of the drug. While the Senate bill does not forbid pharmacists from collecting more than the cash price for a prescription, it does allow them to tell patients when their out-of-pocket costs using their health plan …
Continue Reading Download PDF
Spotlight on 2018 State Drug Legislation: Part 3 – Pharmacist Gag Clauses
Katie Gudiksen, Senior Health Policy Researcher August 28, 2018
*Last Update: This post was written before the end of the 2018 legislative session. For the most recent count of states that passed these legislation, see the Spotlight on 2018 State Drug Legislation Summary: The Year in Review or download our Summary Chart. *Updated 10/10/18: Since the original publication, the federal government enacted laws to ensure a federal ban on pharmaceutical gag-clauses. On Wednesday, October 10, President Trump signed into law both bills passed by Congress to ban gag clauses in pharmacy contracts: the Patient Right to Know Drug Prices …
Continue Reading Download PDF CPR & HCI3 Release State Price Transparency Report Card with Appendix by The Source
Anne Marie Helm, Managing Editor July 8, 2015
Catalyst for Payment Reform (CPR) and the Health Care Incentives Improvement Group (HCI3) just released the third edition of the Report Card on State Price Transparency Laws. The report highlights the five states that received non-failing grades, all of which received different grades from 2014: New Hampshire (A), Colorado (B), Maine (B), Vermont (C) and Virginia (C). A key feature of the report is Appendix I: An Analysis of Popular Legal Arguments Against Price Transparency, authored by The Source’s editors, Jaime S. King and Anne Marie Helm. We thank CPR and HCI3 …
Continue Reading Download PDF